Emergent BioSolutions 관리
관리 기준 확인 1/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Joe Papa
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | less than a year |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 1.7yrs |
| 이사회 평균 재임 기간 | 3.3yrs |
최근 관리 업데이트
Recent updates
Emergent BioSolutions Inc. (NYSE:EBS) Shares Fly 32% But Investors Aren't Buying For Growth
Nov 09
Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic
Nov 08Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way?
Oct 28Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario
Oct 04Little Excitement Around Emergent BioSolutions Inc.'s (NYSE:EBS) Revenues As Shares Take 27% Pounding
Sep 16Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
Aug 18Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 02Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
Jul 15Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09CEO
Joe Papa (68 yo)
less than a year
테뉴어
Mr. Joseph C. Papa, Jr. also known as Joe, is Independent Non-Executive Director of Milestone Pharmaceuticals Inc. since September 3, 2024. Mr. Papa serves as Executive Advisor at Water Street Healthcare P...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive VP | 6.7yrs | US$2.18m | 0.32% $ 1.6m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.6yrs | US$1.68m | 0.30% $ 1.5m | |
| Senior Vice President of Products Business | 1.8yrs | US$1.06m | 0.045% $ 230.7k | |
| CEO, President & Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior VP | less than a year | 데이터 없음 | 0.013% $ 64.5k | |
| Senior VP & Chief Human Resource Officer | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Manufacturing & Bioservices | no data | 데이터 없음 | 0.088% $ 450.1k | |
| Senior VP of Research & Development and Chief Marketing Officer | no data | 데이터 없음 | 데이터 없음 |
1.7yrs
평균 재임 기간
58.5yo
평균 연령
경험이 풍부한 관리: EBS 의 관리팀은 경험 (평균 재직 기간 1.7 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Director | 18.4yrs | US$400.23k | 0.099% $ 506.4k | |
| Independent Director | 19.8yrs | US$394.73k | 0.037% $ 188.1k | |
| Independent Director | 1.1yrs | US$397.50k | 0.027% $ 138.0k | |
| Independent Director | 2.6yrs | US$396.99k | 0.011% $ 54.3k | |
| Independent Director | 4.1yrs | US$405.98k | 0.068% $ 347.5k | |
| Independent Non-Executive Chairman | 20.3yrs | US$535.98k | 0.070% $ 360.7k | |
| Independent Director | 8.1yrs | US$413.48k | 0.068% $ 351.2k | |
| Independent Director | 1.1yrs | US$398.75k | 데이터 없음 | |
| Independent Director | 2.3yrs | US$382.23k | 0.0073% $ 37.4k |
3.3yrs
평균 재임 기간
65yo
평균 연령
경험이 풍부한 이사회: EBS 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.